Product Name

Benzonatate

Name: Benzonatate - LGM Pharma
SKU: 104-31-4

CAS Number

104-31-4

LGM Pharma is an API distributor. LGM Pharma can supply CGMP and/or DMF products, subject to availability and manufacturer requirements. LGM Pharma does not sell or supply APIs or finished dosage products to individual patients, doctors, pharmacies, or any pharmaceutical companies.

Questions? Call our customer API support number 1-(800)-881-8210

Product Name:

Benzonatate

CAS Number:

104-31-4

Indication:

For the symptomatic relief of cough. Has also been applied locally in the oral cavity in adults by releasing the drug from the liquid-filled capsules to provide oropharyngeal anesthesia for conscious intubation.

Mode of Action:

Benzonatate acts peripherally, anesthetizing the stretch receptors of vagal afferent fibers in the alveoli of the lungs, bronchi, and pleura. Since these receptors are responsible for mediating the cough reflex, anesthetizing these receptors result in the inhibiton of cough production. Benzonatate also suppresses transmission of the cough reflex at the level of the medulla where the afferent impulse is transmitted to the motor nerves. When applied locally, Benzonatate binds within the intracellular portion of voltage-gated sodium channels, decreasing the rate of membrane depolarization and increasing the threshold for electrical excitability.

Pharmacodynamics:

Benzonatate, a non-narcotic antitussive agent chemically related to tetracaine and other ester-type local anesthetics, is used to suppress cough associated with both acute and chronic respiratory conditions. The drug acts peripherally by anesthetizing the stretch receptors located in the respiratory passages, lungs, and pleura through the dampening of their activity, which reduces the cough reflex.

Metabolism:

Benzonatate is hydrolyzed to para-aminobenzoic acid (PABA) by plasma esterases

Toxicity:

Restlessness, tremors, seizures and unconsciousness.

IUPAC:

2, 5, 8, 11, 14, 17, 20, 23, 26-nonaoxaoctacosan-28-yl 4-(butylamino)benzoate

ATC:

R05DB01

PubChem:

7699

DrugBank:

DB00868 (APRD00629)

Formula:

C₂₇H₂₉N₅O₆S

Molecular Mass:

603.7419

Synonyms:

Benzonatato [INN-Spanish] Benzonatatum [INN-Latin] Benzononatine

SMILES:

CCCCNC1=CC=C(C=C1)C(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOC

InChi:

MAFMQEKGGFWBAB-UHFFFAOYSA-N

General Reference:

Cohen V, Jellinek SP, Stansfield L, Truong H, Baseluos C, Marshall JP: Cardiac arrest with residual blindness after overdose of tessalonÂ (benzonatate) perles. J Emerg Med. 2009 Nov 4. Pubmed

Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271(e)+A13(1). Any patent infringement and resulting liability is solely at buyer risk.

LGM currently offers Monoclonal Antibodies (mAbs) for non-GMP/R&D use. Please inquire about Monoclonal Antibodies produced under GMP conditions.

Questions? Call our customer API support number 1-(800)-881-8210.

Ask us about this product

API’s From Quality Manufacturers:

Streamlined API supply towards initial research stages as well as larger quantities of cGMP material for clinical trials and product commercialization
Premium quality GMP certified and fully accredited API manufacturing plants
Technical packages as well as access to filed DMF, ASMF or CEP (subject to availability)
Regulatory and technical assistance towards any submission type based on specific customer requirements

Benzonatate

104-31-4

Ask us about this product

API’s From Quality Manufacturers:

Find an API Product